SC 13G ·Filed Nov 17, 2026
Passive investor 5%+ stake
CVKD drugs
CVKD drug pipeline →- ◆ CAD-1005 4/10 Phase 2 completed; pivotal Phase 3 planned (FDA End-of-Phase 2 meeting concluded)
- ◆ tecarfarin 3/10 Phase 3-ready (per company disclosure); no active Phase 2/3 ClinicalTrials.gov record for tecarfarin found in ingested d
- ● frunexian 2/10 Phase 2-ready (trial not yet initiated; no frunexian trial found in available ClinicalTrials.gov data)
- All CVKD drugs, catalysts & trials →
Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002163771-26-000002 |
| Document: 0002163771-26-000002-index.html | 0002163771-26-000002 |
| Document: 0002163771-26-000002.txt | 0002163771-26-000002 |
Track record
16 reports on CVKD
3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +68.89% at T+60 after the Jul 1, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 17, 2026today SC 13G Neutral 4/10 Viewing Entry $1.55 Now $1.85 +19.35% settles Feb 16
- Oct 7, 20265w ago 8-K Bullish 6/10 Entry $0.9723 Now $1.85 +90.27% settles Jan 4
- Aug 31, 202611w ago 8-K Bullish 6/10 Entry $1.75 Now $1.85 +5.71% settles Nov 24
- Jul 21, 202617w ago 8-K Neutral 5/10 Entry $2.17 to $0.9970 Now $1.85 −14.75% ▼ −54.06% −58.03% vs SPY
- Jul 21, 202617w ago EFFECT Neutral 2/10 Entry $2.17 to $0.9970 Now $1.85 −14.75% ▼ −54.06% −58.03% vs SPY
- Jul 1, 202619w ago Press Release Bearish 5/10 Entry $3.60 to $1.12 Now $1.85 +48.61% ▲ +68.89% +71.94% vs SPY
- Jun 29, 202620w ago 8-K Neutral 2/10 Entry $3.34 to $1.32 Now $1.85 −44.61% ▼ −60.48% −64.04% vs SPY
- Jun 18, 202621w ago 8-K Neutral 3/10 Entry $3.50 to $1.06 Now $1.85 −47.14% ▼ −69.71% −71.61% vs SPY
- Jun 15, 202622w ago 144 Bearish 5/10 Entry $3.04 to $1.18 Now $1.85 +39.14% ▲ +61.18% +62.18% vs SPY
- May 7, 202627w ago Press Release Bullish 6/10 Entry $6.02 to $1.96 Now $1.85 −69.27% ▼ −67.44% −71.27% vs SPY
Showing 10 of 16
US Market Status
Market Open · Closes in 25m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers